Stockholders' Equity - Equity Incentives (Details) - USD ($)		12 Months Ended
	Oct. 18, 2024	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022	Nov. 04, 2020	Nov. 03, 2020
Shareholders Equity [Line Items]
Options outstanding (in shares)		108,000	114,000	110,000
Related Party
Shareholders Equity [Line Items]
Common stock issued for consulting agreement (in shares)	25,000
Stock Options
Shareholders Equity [Line Items]
Share-based compensation expense		$ 1,700,000	$ 14,000
Unrecognized compensation expense, net of estimated forfeitures		$ 0
Non-vested shares associated with stock option awards (in shares)		0
2024 Plan
Shareholders Equity [Line Items]
Options authorized for issuance (in shares)		2,800,000
Share-based compensation, number of shares available for grant (in shares)		0
2023 Plan
Shareholders Equity [Line Items]
Options authorized for issuance (in shares)		2,000,000
2023 Plan | Related Party
Shareholders Equity [Line Items]
Common stock issued for consulting agreement (in shares)		295,000
2023 Plan | Restricted Stock Units (RSUs)
Shareholders Equity [Line Items]
Share-based compensation expense		$ 1,200,000
Common stock issued for consulting agreement (in shares)		908,852
2016 Plan
Shareholders Equity [Line Items]
Options authorized for issuance (in shares)					800,000	400,000
Options outstanding (in shares)		100,000	100,000
2011 Plan
Shareholders Equity [Line Items]
Options outstanding (in shares)		8,000	14,000
Share-based compensation , number of additional shares authorized (in shares)		0